ORIC Pharmaceuticals Inc (NAS:ORIC)
$ 9.3 0.37 (4.14%) Market Cap: 627.03 Mil Enterprise Value: 291.11 Mil PE Ratio: 0 PB Ratio: 1.91 GF Score: 40/100

Oric Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 02:00PM GMT
Release Date Price: $5.69 (+3.27%)
Maury Raycroft
(Trades, Portfolio) - Analyst

Hi. My name is Maury Raycroft and then I'm of the biotech analysts at Jefferies. We're going to do a fireside chat today with ORIC. Got Jacob and Dominic with me. Thanks so much for joining us.

Maybe to start off if you guys want to provide a one-minute intro to ORIC.

Jacob Chacko
ORIC Pharmaceuticals, Inc. - President, CEO & Board Member

Sure. Happy to, Maury. Thanks for having us. So ORIC stands for Overcoming Resistance in Cancer, and that, in a nutshell, is the mission of the company. We are focused on small molecule drug development, and primarily in solid tumors, with one exception that we'll talk about, I'm sure, today.

There's a lot of expertise inside the company based on the team

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot